Osaka, Japan

Masatoshi Minagawa

This inventor holds 3 USPTO granted patents. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astellas Pharma Gmbh. Active years: 2002-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masatoshi Minagawa. Retrieved from https://idiyas.com/inventor/masatoshi-minagawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2002-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Masatoshi Minagawa

Introduction

Masatoshi Minagawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrazine and beta-alanine derivatives. With a total of three patents to his name, Minagawa's inventions have the potential to impact various therapeutic applications.

Latest Patents

Minagawa's latest patents include "Pyrazine derivatives and pharmaceutical use thereof," which focuses on a specific pyrazine derivative formula. Another significant patent is "Beta-alanine derivatives and their use as receptor antagonists," detailing a beta-alanine derivative with various substituents that enhance its pharmaceutical properties. These patents reflect his commitment to advancing medical science through innovative chemical compounds.

Career Highlights

Throughout his career, Minagawa has worked with prominent companies in the pharmaceutical industry. He has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH, where he has contributed to the development of new therapeutic agents. His work has been instrumental in pushing the boundaries of pharmaceutical research.

Collaborations

Minagawa has collaborated with esteemed colleagues such as Atsushi Akahane and Kohei Takenaka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Masatoshi Minagawa's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…